Header Logo

Connection

Angela Woodiwiss to Drug Therapy, Combination

This is a "connection" page, showing publications Angela Woodiwiss has written about Drug Therapy, Combination.
Connection Strength

0,167
  1. Beta1- and alpha2c-adrenoreceptor variants as predictors of clinical aspects of dilated cardiomyopathy in people of African ancestry. Cardiovasc J Afr. 2008 Jul-Aug; 19(4):188-93.
    View in: PubMed
    Score: 0,073
  2. Impact of beta2-adrenoreceptor gene variants on cardiac cavity size and systolic function in idiopathic dilated cardiomyopathy. Pharmacogenomics J. 2007 Oct; 7(5):339-45.
    View in: PubMed
    Score: 0,065
  3. Change in blood pressure predicts regression of cardiac hypertrophy in patients of African ancestry receiving agents influencing the renin-angiotensin system. J Hum Hypertens. 2005 Aug; 19(8):659-61.
    View in: PubMed
    Score: 0,015
  4. A phosphodiesterase inhibitor promotes the premature development of adverse cardiac remodelling mediated by beta-adrenergic activation in hypertension. S Afr Med J. 2004 Oct; 94(10):833-4.
    View in: PubMed
    Score: 0,014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.